<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Eli Lilly And Company</title><link href="http://diabetesinfoandtreatment.com/topic/eli-lilly-and-company" rel="alternate"></link><id>http://diabetesinfoandtreatment.com/topic/eli-lilly-and-company</id><updated>2010-11-30T12:54:39Z</updated><entry><title>Lilly Announces China R&amp;D Center in Major Strategic Departure</title><link href="http://diabetesinfoandtreatment.com/diabetes/lilly-announces-china-center-major-strategic-departure-4274118a" rel="alternate"></link><updated>2010-11-05T06:41:07Z</updated><author><name>SeekingAlpha</name></author><id>tag:diabetesinfoandtreatment.com,2010-11-05:/diabetes/lilly-announces-china-center-major-strategic-departure-4274118a/</id><summary type="html">...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Sciences"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Contract Research Organizations"></category><category term="United States"></category><category term="China"></category><category term="Asia"></category><category term="Eli Lilly and Company"></category><category term="Stanford University School of Medicine"></category><category term="Indianapolis"></category><category term="Indiana University School of Medicine"></category><category term="Actos"></category><category term="Singapore"></category><category term="Shanghai"></category><category term="East Asia"></category><category term="Byetta"></category><category term="Covance Inc."></category><category term="Humalog"></category><category term="Fudan University"></category><category term="Humulin"></category><category term="New York Stock Exchange"></category><category term="Eli Lilly and Company Foundation"></category><category term="Bei Betty Zhang"></category><category term="David Moller"></category><category term="China Diabetes Society"></category><category term="European Foundation for the Study"></category></entry><entry><title>Humalog Coupons</title><link href="http://diabetesinfoandtreatment.com/diabetes/humalog-coupons-4639418a" rel="alternate"></link><updated>2010-11-30T12:54:39Z</updated><author><name>Mahalo</name></author><id>tag:diabetesinfoandtreatment.com,2010-11-30:/diabetes/humalog-coupons-4639418a/</id><summary type="html">...</summary><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 1 Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="Eli Lilly and Company"></category><category term="Humalog"></category><category term="Lilly Cares"></category></entry><entry><title>For Investors, Diabetes Is a Growth Industry</title><link href="http://diabetesinfoandtreatment.com/diabetes/investors-diabetes-growth-industry-3409238a" rel="alternate"></link><updated>2010-10-27T07:28:35Z</updated><author><name>SmartMoney</name></author><id>tag:diabetesinfoandtreatment.com,2010-10-27:/diabetes/investors-diabetes-growth-industry-3409238a/</id><summary type="html">...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Health Care Services Sector"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="India"></category><category term="New York"></category><category term="Sweden"></category><category term="Illinois"></category><category term="New Hampshire"></category><category term="Japan"></category><category term="Europe"></category><category term="Denver"></category><category term="Nashville"></category><category term="Tennessee"></category><category term="Standard &amp; Poor's"></category><category term="Food and Drug Administration"></category><category term="France"></category><category term="Asia"></category><category term="University of Chicago Hospitals &amp; Health System"></category><category term="Eli Lilly and Company"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Western Europe"></category><category term="American Diabetes Association"></category><category term="Pfizer Inc."></category><category term="International Diabetes Federation"></category><category term="Avandia"></category><category term="Sanofi-Aventis SA"></category><category term="East Asia"></category><category term="South Asia"></category><category term="Nordic Countries"></category><category term="Byetta"></category><category term="Stephens Inc."></category><category term="F. Hoffman-La Roche Ltd."></category><category term="Vontobel Holding AG"></category><category term="Baxter International Inc."></category><category term="Exubera"></category><category term="Amylin Pharmaceuticals Inc."></category><category term="APP Pharmaceuticals Inc."></category><category term="Fresenius Medical Care AG &amp; Co. KGaA"></category><category term="Lantus"></category><category term="Nektar Therapeutics Inc."></category><category term="Andreas Dirnagl"></category><category term="Andrew Weiss"></category><category term="Gambro AB"></category><category term="Steven Silver"></category><category term="Specialized Health Care Services"></category><category term="Fresenius"></category><category term="Victoza"></category><category term="Onglyza"></category><category term="AgaMatrix Inc."></category><category term="Elron Electronic Industries Ltd."></category><category term="Renal Care Group Inc."></category></entry><entry><title>Diabetes Drug Byetta May Aid Weight Loss in Obese Patients</title><link href="http://diabetesinfoandtreatment.com/diabetes/diabetes-drug-byetta-aid-weight-loss-obese-patients-3010431a" rel="alternate"></link><updated>2010-10-24T09:14:57Z</updated><author><name>Drugs.com</name></author><id>tag:diabetesinfoandtreatment.com,2010-10-24:/diabetes/diabetes-drug-byetta-aid-weight-loss-obese-patients-3010431a/</id><summary type="html">...</summary><category term="Diet and Nutrition"></category><category term="Weight Loss"></category><category term="Exercise and Fitness"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Diabetic Diets"></category><category term="Prediabetes"></category><category term="Obesity"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Washington, DC"></category><category term="Eli Lilly and Company"></category><category term="Indianapolis"></category><category term="The Endocrine Society"></category><category term="Byetta"></category><category term="Amylin Pharmaceuticals Inc."></category><category term="Body Weight"></category><category term="Michael Trautmann"></category></entry><entry><title>Baneful Byetta</title><link href="http://diabetesinfoandtreatment.com/diabetes/baneful-byetta-2301326a" rel="alternate"></link><updated>2010-10-21T09:39:25Z</updated><author><name>Forbes</name></author><id>tag:diabetesinfoandtreatment.com,2010-10-21:/diabetes/baneful-byetta-2301326a/</id><summary type="html">...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Pancreatitis"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="New York"></category><category term="Denmark"></category><category term="New Jersey"></category><category term="Japan"></category><category term="United Kingdom"></category><category term="San Diego"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="Asia"></category><category term="Eli Lilly and Company"></category><category term="Merck &amp; Co. Inc."></category><category term="AstraZeneca Group"></category><category term="Western Europe"></category><category term="Bristol-Myers Squibb Company"></category><category term="American Diabetes Association"></category><category term="East Asia"></category><category term="Nordic Countries"></category><category term="Byetta"></category><category term="Novo Nordisk AS"></category><category term="Whitehouse Station"></category><category term="Amylin Pharmaceuticals Inc."></category><category term="Januvia"></category><category term="Takeda Pharmaceutical Co. Ltd."></category><category term="James Malone"></category><category term="England"></category><category term="London (England)"></category><category term="Orville Kolterman"></category></entry><entry><title>The Diabetes-Industrial Complex</title><link href="http://diabetesinfoandtreatment.com/prediabetes/diabetesindustrial-complex-2295036a" rel="alternate"></link><updated>2010-10-21T09:35:50Z</updated><author><name>Forbes</name></author><id>tag:diabetesinfoandtreatment.com,2010-10-21:/prediabetes/diabetesindustrial-complex-2295036a/</id><summary type="html">...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Prediabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="Centers for Disease Control and Prevention"></category><category term="Eli Lilly and Company"></category><category term="Novo Nordisk AS"></category><category term="Amylin Pharmaceuticals Inc."></category><category term="Walter Bagehot"></category><category term="David Kliff"></category></entry><entry><title>Gila Monster Spit Could Be a Weight-Loss Hit</title><link href="http://diabetesinfoandtreatment.com/diabetes/gila-monster-spit-weightloss-hit-2904312a" rel="alternate"></link><updated>2010-10-23T02:53:11Z</updated><author><name>EverydayHealth.com</name></author><id>tag:diabetesinfoandtreatment.com,2010-10-23:/diabetes/gila-monster-spit-weightloss-hit-2904312a/</id><summary type="html">...</summary><category term="Weight Loss"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="North America"></category><category term="Chicago"></category><category term="Food and Drug Administration"></category><category term="Mexico"></category><category term="Centers for Disease Control and Prevention"></category><category term="Eli Lilly and Company"></category><category term="American Diabetes Association"></category><category term="Byetta"></category><category term="UNC School of Medicine"></category><category term="Amylin Pharmaceuticals Inc."></category><category term="Body Weight"></category><category term="John Buse"></category></entry><entry><title>Prescription Drugs Heist</title><link href="http://diabetesinfoandtreatment.com/photo/prescription-drugs-heist-2197296p" rel="alternate"></link><updated>2010-03-26T16:41:28Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-03-26:/photo/prescription-drugs-heist-2197296p/</id><summary type="html">The &lt;a title="Eli Lilly and Company" href="/topic/Eli+Lilly+and+Company" &gt;Eli Lilly&lt;/a&gt; warehouse is seen here in Enfield, &lt;a title="Connecticut" href="/topic/Connecticut" &gt;Conn.&lt;/a&gt;, Tuesday, March 16, 2010.  Authorities say tens of millions of dollars worth of prescription drugs have been stolen in a brazen, well-planned heist at a pharmaceutical company's regional warehouse in Connecticut.  (AP Photo/Journal Inquirer/Leslloyd F. Alleyne) MANDATORY CREDIT
&lt;div id="copyright"&gt;&lt;div&gt;
        Copy...</summary><category term="Crime"></category><category term="Grand Larceny"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="Connecticut"></category><category term="Eli Lilly and Company"></category></entry><entry><title>Eli Lilly Reorganization</title><link href="http://diabetesinfoandtreatment.com/photo/eli-lilly-reorganization-1736502p" rel="alternate"></link><updated>2010-04-01T19:34:49Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-04-01:/photo/eli-lilly-reorganization-1736502p/</id><summary type="html">FILE - In this Jan 25, 2006 file photo, The &lt;a title="Eli Lilly and Company" href="/topic/Eli+Lilly+and+Company" &gt;Eli Lilly and Company&lt;/a&gt; headquarters in pictured in &lt;a title="Indianapolis" href="/topic/Indianapolis" &gt;Indianapolis&lt;/a&gt;. Drugmaker Eli Lilly &amp;amp; Co. said Monday, Sept. 14, 2009, that it will eliminate 5,500 jobs, or nearly 14 percent of its staff, and reorganize into five business units in order to slash costs and speed up development of potential new drugs. (AP Photo/Darron Cum...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Eli Lilly and Company"></category><category term="Indianapolis"></category></entry></feed>
